Seattle, WA, United States of America

Steven B Levery


Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 92(Granted Patents)


Company Filing History:


Years Active: 1989-2001

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Steven B. Levery

Introduction

Steven B. Levery is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of cancer research. With a total of nine patents to his name, Levery has made strides in developing innovative solutions for cancer detection and treatment. His work focuses on the use of glycosphingolipids as tumor-associated antigens, which has implications for both diagnostics and therapeutics.

Latest Patents

One of Levery's latest patents involves extended type 1 chain glycosphingolipids as tumor-associated antigens. This invention provides a variety of compounds that are useful as immunogens and tumor markers. The methods disclosed in this patent relate to the detection of cancer, highlighting that extended forms of the lacto-series type 1 chain are present in various cancer tissues. Additionally, the invention includes a cell line and the monoclonal antibody produced from it, which has numerous applications in diagnostic and therapeutic methods.

Career Highlights

Throughout his career, Steven B. Levery has worked with notable organizations such as the Biomembrane Institute and the Fred Hutchinson Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Levery has collaborated with esteemed colleagues, including Sen-itiroh Hakomori and Edward D. Nudelman. These partnerships have further enriched his research and innovation in cancer detection and treatment.

Conclusion

Steven B. Levery's work exemplifies the impact of innovative research in the medical field, particularly in cancer detection and treatment. His patents and collaborations continue to pave the way for advancements in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…